Clinical Trials Directory

Trials / Sponsors / Jerry Vockley, MD, PhD

Jerry Vockley, MD, PhD

Academic / Other · 8 registered clinical trials — 4 currently recruiting.

StatusTrialPhaseStarted
RecruitingStudy to Evaluate the Use of Triheptanoin in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCA
Medium-chain Acyl-CoA Dehydrogenase Deficiency
Phase 22026-07-01
SuspendedStudy of Triheptanoin for the Prevention of Hypoglycemia in Patients With Medium Chain Acyl-CoA Dehydrogenase
Medium-chain Acyl-CoA Dehydrogenase Deficiency
Phase 22026-02-01
Enrolling By InvitationAn Individual Patient, Open Label Study to Use ACER-001 to Treat Combined D,L-2 Hydroxyglutaric Aciduria (C-2H
Combined D,L-2-hydroxyglutaric Aciduria
Phase 12025-07-30
RecruitingStudy of Sodium Phenylbutyrate (ACER-001) for the Treatment of Pediatric and Adults Patients With Medium Chain
Medium-chain Acyl-CoA Dehydrogenase Deficiency
Phase 22025-06-30
SuspendedStudy of Sodium Phenylbutyrate (ACER-001) for the Treatment of Patients With Medium Chain Acyl-CoA Dehydrogena
Medium-chain Acyl-CoA Dehydrogenase Deficiency
Phase 22024-04-01
Enrolling By InvitationGenome Sequencing in the Intensive Care Unit Population
Infant, Newborn, Disease, Genetic Disease
N/A2020-07-13
No Longer AvailableCompassionate Use of Triheptanoin (C7) for Inherited Disorders of Energy Metabolism
Very Long-chain acylCoA Dehydrogenase (VLCAD) Deficiency, Carnitine Palmitoyltransferase Deficiencies (CPT1, CPT2), Mitochondrial Trifunctional Protein Deficiency
——
No Longer AvailableTreatment With UX007 for a Single Patient With GLUT1 Deficiency Syndrome
Glucose Transporter 1 Deficiency Syndrome
——
Jerry Vockley, MD, PhD — clinical trials (8) · Clinical Trials Directory